empty

Suggested Learning

MHRA recalls five batches of bimatoprost eye drops

 

The MHRA has recalled five batches of Bimatoprost Aspire eye drops, with pharmacies required to stop dispensing affected supplies.

The watchdog issued a class 3 medicines recall for five batches of Bimatoprost Aspire 0.3mg/ml eye drops, solution in single dose container 0.4ml x 30 earlier today. This precautionary measure is being taken “due to the identification of some variability in the thickness of plastic of the single dose containers,” which has made it difficult for some patients to squeeze the solution from the container.

Healthcare professionals are advised to stop supplying the affected batches immediately and to quarantine all remaining stock before returning it to their supplier.




This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Independent Pharmacist's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.